Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M S Lennard

Showing results (1-10 of 118) with videos related to

Pageof 12
Sort By:
Pharmacology & Therapeutics|January 1, 1989
The polymorphic oxidation of beta-adrenoceptor antagonistsM S Lennard
Drug Safety|July 1, 1993
Genetically determined adverse drug reactions involving metabolismM S Lennard
Pharmacology & Toxicology|October 1, 1990
Genetic polymorphism of sparteine/debrisoquine oxidation: a reappraisalM S Lennard
British Journal of Clinical Pharmacology|June 1, 1991
Clinical pharmacology through the looking glass: reflections on the racemate vs enantiomer debateM S Lennard
Klinische Wochenschrift|April 1, 1985
Oxidation phenotype and the metabolism and action of beta-blockersM S Lennard
Journal of Chromatography|July 12, 1985
Quantitative analysis of metoprolol and three of its metabolites in urine and liver microsomes by high-performance liquid chromatographyM S Lennard
Hepatology (Baltimore, Md.)|January 1, 1989
Metoprolol-induced hepatitis: is the rate of oxidation related to drug-induced hepatotoxicity?M S Lennard
Journal of Chromatography. B, Biomedical Applications|October 25, 1996
Quantitative analysis of amitriptyline and nortriptyline in human plasma and liver microsomal preparations by high-performance liquid chromatographyP Ghahramani, M S Lennard
Journal of Chromatography|February 27, 1985
Timolol determination in plasma and urine by high-performance liquid chromatography with ultraviolet detectionM S Lennard, S Parkin
Journal of Chromatography|January 14, 1983
Rapid determination of metoprolol and alpha-hydroxymetoprolol in human plasma and urine by high-performance liquid chromatographyM S Lennard, J H Silas
Pageof 12

Showing results (1-10 of 118) with videos related to

Sort By:
Pageof 12
Pharmacology & Therapeutics|January 1, 1989
The polymorphic oxidation of beta-adrenoceptor antagonistsM S Lennard
Drug Safety|July 1, 1993
Genetically determined adverse drug reactions involving metabolismM S Lennard
Pharmacology & Toxicology|October 1, 1990
Genetic polymorphism of sparteine/debrisoquine oxidation: a reappraisalM S Lennard
British Journal of Clinical Pharmacology|June 1, 1991
Clinical pharmacology through the looking glass: reflections on the racemate vs enantiomer debateM S Lennard
Klinische Wochenschrift|April 1, 1985
Oxidation phenotype and the metabolism and action of beta-blockersM S Lennard
Journal of Chromatography|July 12, 1985
Quantitative analysis of metoprolol and three of its metabolites in urine and liver microsomes by high-performance liquid chromatographyM S Lennard
Hepatology (Baltimore, Md.)|January 1, 1989
Metoprolol-induced hepatitis: is the rate of oxidation related to drug-induced hepatotoxicity?M S Lennard
Journal of Chromatography. B, Biomedical Applications|October 25, 1996
Quantitative analysis of amitriptyline and nortriptyline in human plasma and liver microsomal preparations by high-performance liquid chromatographyP Ghahramani, M S Lennard
Journal of Chromatography|February 27, 1985
Timolol determination in plasma and urine by high-performance liquid chromatography with ultraviolet detectionM S Lennard, S Parkin
Journal of Chromatography|January 14, 1983
Rapid determination of metoprolol and alpha-hydroxymetoprolol in human plasma and urine by high-performance liquid chromatographyM S Lennard, J H Silas
Pageof 12